Zenapax to Treat Multiple Sclerosis

NCT00001934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Zenapax

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)